RxDoctor Payments Data

William Fancher

Allergy · Birmingham, ALNPI 1578026100

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,583 of the $3,383 with a category attached, or 76.4%. 22 manufacturers reported payments, led by Sanofi at 31.2% of the total. 2025 is the largest year on record at $1,271, 9.8 times the $130 reported in 2022.

$3,383in general payments, 2019–2025

Across 119 payments — averaging $28.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1K
  • AstraZeneca$530
  • Regeneron Healthcare Solutions, Inc.$324
  • Biocryst US Sales Co., LLC$253
  • GSK$193
  • ARS Pharmaceuticals Operations, Inc.$189
  • plus $839 from 16 others

What the payments were for

  • Grants$80024%
  • Food & beverage$2,58376%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy providers in Alabamato place this figure against a meaningful peer group, so we don't.

Other allergy in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →